Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2005
03/17/2005US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
03/17/2005US20050058634 Coupling monosaccharide into glycoprotein; oxidation; increasing therapeutic efficiency
03/17/2005CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk
03/17/2005CA2537145A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
03/17/2005CA2536099A1 Partitioning of recombinant proteins into e.coli supernatant or periplasm
03/16/2005EP1514934A2 Biosynthetic binding protein for cancer marker
03/16/2005EP1514932A2 Glucagon receptors
03/16/2005EP1514931A1 Immunosuppressant target proteins
03/16/2005EP1514926A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof
03/16/2005EP1514876A2 Antibody against prostate stem cell antigen (PSCA)
03/16/2005EP1514556A1 Botulinum toxin pharmaceutical compositions
03/16/2005EP1513945A2 Method for universal enzymatic production of bioactive peptides
03/16/2005EP1513940A2 Methods and materials for the production of lactic acid in yeast
03/16/2005EP1513939A2 Fermentation process using specific oxygen uptake rates as a process control
03/16/2005EP1513936A2 Use of repression blocking sequences in methods for enhancing gene expression
03/16/2005EP1513935A1 Vectors for expression of biotinylated proteins in mammalian cells, and their use for identification of protein-nucleic acid interactions in vivo
03/16/2005EP1513929A2 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
03/16/2005EP1513923A2 Methods and materials for the production of d-lactic acid in yeast
03/16/2005EP1513867A2 Extracellular junctional adhesion molecules
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
03/16/2005EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders
03/16/2005EP1513397A2 Transgenic ungulates capable of human antibody production
03/16/2005EP1470216A4 Hair follicle growth
03/16/2005EP1366360A4 Methods for large scale protein matching
03/16/2005EP1343880A4 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
03/16/2005EP0907737B1 Il-6 mutein
03/16/2005EP0861329B1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
03/16/2005EP0763127B1 Deblocking the common pathway of aromatic amino acid synthesis
03/16/2005CN1596313A Humanized collagen antibodies and related methods
03/16/2005CN1596310A Method for producing a recombinant polypeptide
03/16/2005CN1596309A Recombinant DNA encoding the major allergen of plantago lanceolata pollen, PLA L 1, and applications thereof
03/16/2005CN1596305A Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
03/16/2005CN1596304A Protein knobs
03/16/2005CN1596302A Cell culture process
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596268A Chromatographic purification of recombinant human erythropoietin
03/16/2005CN1594587A Preparation for fungus extracellular polysaccharide compound and application thereof
03/16/2005CN1594582A Process for preparing human apolipoprotein A-I
03/16/2005CN1594581A Method for preparing human brain natriuretic peptide by genetic engineering recombination technology
03/16/2005CN1593646A Soybean peptide, its preparation and application
03/16/2005CN1193042C C-peptide for the improved production of insulin and insulin analogues
03/16/2005CN1193041C New human protein with the function of inhibiting cancer cell growth and its encoding sequence
03/16/2005CN1193040C New human protein with the function of inhibiting tumor cell growth and its encoding sequence
03/15/2005US6867288 Polycystic kidney disease gene
03/15/2005US6867176 Method for preparing zinc-oligopeptide easily absorbable by the human body
03/15/2005US6867042 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis
03/15/2005US6867030 Peptide for use in the treatment of cholesterol storage defects
03/15/2005US6867020 Nucleotide sequences coding preferential polypeptides associated with blood formation; for use in treatment of blood disorders
03/15/2005US6867016 Reagents and methods useful for detecting diseases of the gastrointestinal tract
03/15/2005US6867013 Methods of screening for antagonists and agonists of polypeptides having kinase functions
03/15/2005US6866997 Designing a protein which is capable of binding to any predefined nucleic acid sequence
03/15/2005CA2255659C Neuroactive peptides
03/15/2005CA2170034C Recombinant humanized anti-human immunodeficiency virus antibody
03/10/2005WO2005021777A2 Uses of spatial configuration to modulate protein function
03/10/2005WO2005021764A2 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
03/10/2005WO2005021762A2 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
03/10/2005WO2005021739A1 ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR
03/10/2005WO2005021723A2 Nucleic acid molecules from rice controlling abiotic stress tolerance
03/10/2005WO2005021722A2 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
03/10/2005WO2005021711A2 Approach for obtaining monoclonal antibodies to cell surface proteins
03/10/2005WO2005021592A2 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005WO2005021579A2 Epo mimetic peptides and fusion proteins
03/10/2005WO2005021514A1 Novel unnatural histidine analog amino acid
03/10/2005WO2005020927A2 Method of promoting graft survival with anti-tissue factor antibodies
03/10/2005WO2005010170A9 Fermentation medium based on a highly hydrolized protein substrate
03/10/2005WO2004101768A3 Recombinant comamonas testosreroni 5-mgam-4d amids and carboxylic acid production
03/10/2005WO2004081027A3 Neoplasm specific antibodies and uses thereof
03/10/2005WO2004073393A8 Immunogene adherence and method of making and using same
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003065003A3 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054828 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054073 Cytidine deaminase
03/10/2005US20050054067 Process for producing dipeptide,l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase
03/10/2005US20050054061 Using transgenic gramnegative bacteria as bioreactor for fermentation of histidine to be used in medicine, cosmetics and animal feeds
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054044 Enhancing in vitro translation via maintenance of serine, cysteine, cytosine triphosphate and uridine triphosphate concentration in coupled transcription/translation mixture
03/10/2005US20050054038 High level constitutive production of anthrax protective antigen
03/10/2005US20050054035 Testicular carnitine transporter and its gene
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050054032 Methods of decoupling reaction scale and protein synthesis yield in batch mode
03/10/2005US20050053997 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053925 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/10/2005US20050053924 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053920 Retrovirus from the HIV group and its use
1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1125